Journal Article Summary
The article investigates the effects of low-dose aspirin on the risk of stroke and intracerebral bleeding in healthy older adults. This topic is important because low-dose aspirin is commonly used for preventing cardiovascular events, but its effectiveness and safety in older populations, who are at higher risk for bleeding, have not been thoroughly established. Understanding the balance between the potential benefits of reducing ischemic strokes and the risks of increased bleeding is crucial for making informed healthcare decisions for older individuals.
The study analyzed data from the ASPREE trial, which included over 19,000 older adults without cardiovascular disease, who were randomly assigned to receive either daily low-dose aspirin or a placebo. The findings revealed a significant 38% increase in the risk of intracranial bleeding among those taking aspirin, while there was no statistically significant reduction in the incidence of ischemic strokes. Specifically, 1.1% of participants on aspirin experienced intracranial bleeding compared to 0.8% in the placebo group, indicating that the risks of bleeding may outweigh any potential benefits of stroke prevention in this population.
Limitations of the study include a lower-than-expected number of stroke and bleeding events, which may affect the robustness of the findings. Additionally, the results primarily reflect a predominantly White population with good access to healthcare, limiting generalizability to more diverse groups. Patients should discuss these findings with their healthcare providers, especially if they are considering low-dose aspirin for stroke prevention, as the increased risk of bleeding may be particularly concerning for older adults who are more prone to falls and head injuries.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Cloud Geoffrey C., Williamson Jeff D., Thao Le Thi Phuong, Tran Cammie, Eaton Charles B., Wolfe Rory, Nelson Mark R., Reid Christopher M., et al.. Low-Dose Aspirin and the Risk of Stroke and Intracerebral Bleeding in Healthy Older People. JAMA Network Open 2023. DOI: 10.1001/jamanetworkopen.2023.25803. PMID: 37494038. PMCID: PMC10372701.
Featured Pill Pals Product
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over --- Generic For Bayer Low Dose --- Time Cap Labs --- Over The Counter
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over — Generic For Bayer Low Dose — Time Cap Labs — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
